JP2013505255A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013505255A5 JP2013505255A5 JP2012529909A JP2012529909A JP2013505255A5 JP 2013505255 A5 JP2013505255 A5 JP 2013505255A5 JP 2012529909 A JP2012529909 A JP 2012529909A JP 2012529909 A JP2012529909 A JP 2012529909A JP 2013505255 A5 JP2013505255 A5 JP 2013505255A5
- Authority
- JP
- Japan
- Prior art keywords
- digestive enzyme
- multiparticulate
- coating
- enzyme composition
- lipase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000038379 digestive enzymes Human genes 0.000 claims 42
- 108091007734 digestive enzymes Proteins 0.000 claims 42
- 239000011324 bead Substances 0.000 claims 24
- 239000000203 mixture Substances 0.000 claims 24
- 108091005804 Peptidases Proteins 0.000 claims 15
- 239000004365 Protease Substances 0.000 claims 15
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 15
- 239000011248 coating agent Substances 0.000 claims 13
- 238000000576 coating method Methods 0.000 claims 13
- 239000002702 enteric coating Substances 0.000 claims 10
- 238000009505 enteric coating Methods 0.000 claims 10
- 230000000694 effects Effects 0.000 claims 9
- 235000019626 lipase activity Nutrition 0.000 claims 9
- 102000004882 Lipase Human genes 0.000 claims 7
- 108090001060 Lipase Proteins 0.000 claims 7
- 239000004367 Lipase Substances 0.000 claims 6
- 235000019421 lipase Nutrition 0.000 claims 6
- 239000002552 dosage form Substances 0.000 claims 4
- 208000035467 Pancreatic insufficiency Diseases 0.000 claims 2
- 206010033645 Pancreatitis Diseases 0.000 claims 2
- 235000012054 meals Nutrition 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 206010000087 Abdominal pain upper Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24346709P | 2009-09-17 | 2009-09-17 | |
| US61/243,467 | 2009-09-17 | ||
| PCT/US2010/049203 WO2011035079A1 (en) | 2009-09-17 | 2010-09-17 | Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013505255A JP2013505255A (ja) | 2013-02-14 |
| JP2013505255A5 true JP2013505255A5 (enExample) | 2013-11-07 |
| JP5877399B2 JP5877399B2 (ja) | 2016-03-08 |
Family
ID=43730817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012529909A Expired - Fee Related JP5877399B2 (ja) | 2009-09-17 | 2010-09-17 | 膵炎及び膵不全を治療するための膵酵素組成物及び方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8784884B2 (enExample) |
| EP (1) | EP2477645B1 (enExample) |
| JP (1) | JP5877399B2 (enExample) |
| KR (1) | KR101771752B1 (enExample) |
| CN (2) | CN102630164B (enExample) |
| AR (1) | AR078291A1 (enExample) |
| AU (1) | AU2010295494B2 (enExample) |
| BR (1) | BR112012005837A8 (enExample) |
| CA (1) | CA2774269C (enExample) |
| CL (1) | CL2012000658A1 (enExample) |
| CO (1) | CO6531419A2 (enExample) |
| ES (1) | ES2690661T3 (enExample) |
| HK (1) | HK1218886A1 (enExample) |
| IL (2) | IL218656A (enExample) |
| MX (1) | MX2012003214A (enExample) |
| MY (1) | MY161843A (enExample) |
| NZ (1) | NZ599143A (enExample) |
| RU (1) | RU2570376C2 (enExample) |
| SA (1) | SA110310695B1 (enExample) |
| TW (2) | TW201639545A (enExample) |
| UY (1) | UY32896A (enExample) |
| WO (1) | WO2011035079A1 (enExample) |
| ZA (1) | ZA201202761B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
| EP2079445B1 (en) | 2007-02-20 | 2015-11-04 | Aptalis Pharma Limited | Stable digestive enzyme compositions |
| WO2009109856A2 (en) | 2008-03-07 | 2009-09-11 | Axcan Pharma Inc. | Method for detecting infectious parvovirus in pharmaceutical preparations |
| EP2621476B8 (en) * | 2010-10-01 | 2020-12-23 | Société des Produits Nestlé S.A. | Enteric coated, low-strength pancrelipase formulations |
| RU2602183C2 (ru) * | 2011-08-08 | 2016-11-10 | Апталис Фарма Лтд. | Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты |
| US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
| WO2015020943A2 (en) | 2013-08-09 | 2015-02-12 | Aptalis Pharma Ltd. | Digestive enzyme composition suitable for enteral administration |
| FR3079146B1 (fr) * | 2018-03-23 | 2020-04-17 | Karim Ioualalen | Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive. |
| WO2021202363A1 (en) * | 2020-03-30 | 2021-10-07 | Wall Jai | Combined animal-derived and synthetically produced pancreatic enzyme replacement therapy |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1509866A (en) | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
| US4447412A (en) | 1983-02-01 | 1984-05-08 | Bilton Gerald L | Enzyme-containing digestive aid compostions |
| US5578304A (en) | 1992-06-22 | 1996-11-26 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| US5302400A (en) | 1992-06-22 | 1994-04-12 | Digestive Care Inc. | Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids |
| US5260074A (en) | 1992-06-22 | 1993-11-09 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| US5460812A (en) | 1992-06-22 | 1995-10-24 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| DE4227385A1 (de) | 1992-08-19 | 1994-02-24 | Kali Chemie Pharma Gmbh | Pankreatinmikropellets |
| DE69728857T3 (de) | 1996-02-09 | 2010-02-18 | Quadrant Drug Delivery Ltd., Ruddington | Feste arzneimittel enthaltend trehalose |
| US5750104A (en) | 1996-05-29 | 1998-05-12 | Digestive Care Inc. | High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith |
| US20010046493A1 (en) | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
| CN1156308C (zh) * | 2002-04-19 | 2004-07-07 | 北京世诺医药科技有限公司 | 多酶组合胶囊 |
| US20040132826A1 (en) * | 2002-10-25 | 2004-07-08 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
| EP1596838A2 (en) | 2003-02-11 | 2005-11-23 | Torrent Pharmaceuticals Ltd | Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent |
| AU2004285558A1 (en) * | 2003-10-29 | 2005-05-12 | Altus Pharmaceuticals Inc. | Non-pancreatic proteases for controlling plasma cholecystokinin (CCK) concentration and for treating pain |
| US7387793B2 (en) | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
| US7470435B2 (en) | 2003-11-17 | 2008-12-30 | Andrx Pharmaceuticals, Llc | Extended release venlafaxine formulation |
| DE602005009677D1 (de) | 2004-03-22 | 2008-10-23 | Solvay Pharm Gmbh | Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden |
| DK1755656T3 (da) * | 2004-05-24 | 2010-10-04 | Novozymes As | Enzymer til farmaceutisk anvendelse |
| HUE031245T2 (en) | 2004-10-14 | 2017-06-28 | Lilly Co Eli | Preparations containing lipase, protease and amylase for the treatment of pancreatic insufficiency |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| CA2612648A1 (en) * | 2005-06-24 | 2006-12-28 | Novozymes A/S | Lipases for pharmaceutical use |
| US20070025977A1 (en) | 2005-07-21 | 2007-02-01 | Mulberg Andrew E | Method of treating steatorrhea in infants |
| MX2008000850A (es) | 2005-07-29 | 2008-03-18 | Solvay Pharm Gmbh | Procedimientos para la fabricacion de polvo de pancreatina esterilizada. |
| US11266607B2 (en) * | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US8071089B2 (en) | 2005-11-01 | 2011-12-06 | Bio-Cat, Inc. | Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency |
| MY147954A (en) * | 2006-05-26 | 2013-02-15 | Nestec Sa | Methods of use and nutritional compositions of touchi extract |
| US20080199448A1 (en) * | 2007-02-16 | 2008-08-21 | Ross Mairi R | Enzyme composition for improving food digestion |
| US20090117180A1 (en) | 2007-02-20 | 2009-05-07 | Giovanni Ortenzi | Stable digestive enzyme compositions |
| EP2079445B1 (en) | 2007-02-20 | 2015-11-04 | Aptalis Pharma Limited | Stable digestive enzyme compositions |
| US20110171294A1 (en) | 2008-09-30 | 2011-07-14 | Dsm Ip Assets B.V. | Enzyme composition and application thereof in the treatment of pancreatic insufficiency |
-
2009
- 2009-09-28 US US12/568,064 patent/US8784884B2/en active Active
-
2010
- 2010-09-16 TW TW105126319A patent/TW201639545A/zh unknown
- 2010-09-16 TW TW099131496A patent/TWI572372B/zh not_active IP Right Cessation
- 2010-09-17 CA CA2774269A patent/CA2774269C/en not_active Expired - Fee Related
- 2010-09-17 WO PCT/US2010/049203 patent/WO2011035079A1/en not_active Ceased
- 2010-09-17 RU RU2012113253/15A patent/RU2570376C2/ru active
- 2010-09-17 NZ NZ599143A patent/NZ599143A/en not_active IP Right Cessation
- 2010-09-17 ES ES10817867.4T patent/ES2690661T3/es active Active
- 2010-09-17 KR KR1020127009516A patent/KR101771752B1/ko not_active Expired - Fee Related
- 2010-09-17 AR ARP100103408A patent/AR078291A1/es not_active Application Discontinuation
- 2010-09-17 AU AU2010295494A patent/AU2010295494B2/en not_active Ceased
- 2010-09-17 CN CN201080041366.3A patent/CN102630164B/zh not_active Expired - Fee Related
- 2010-09-17 CN CN201510490337.XA patent/CN105214073A/zh active Pending
- 2010-09-17 JP JP2012529909A patent/JP5877399B2/ja not_active Expired - Fee Related
- 2010-09-17 MY MYPI2012001215A patent/MY161843A/en unknown
- 2010-09-17 BR BR112012005837A patent/BR112012005837A8/pt not_active Application Discontinuation
- 2010-09-17 EP EP10817867.4A patent/EP2477645B1/en not_active Revoked
- 2010-09-17 MX MX2012003214A patent/MX2012003214A/es active IP Right Grant
- 2010-09-17 UY UY0001032896A patent/UY32896A/es not_active Application Discontinuation
- 2010-09-18 SA SA110310695A patent/SA110310695B1/ar unknown
-
2012
- 2012-03-15 IL IL218656A patent/IL218656A/en active IP Right Grant
- 2012-03-15 CL CL2012000658A patent/CL2012000658A1/es unknown
- 2012-03-26 CO CO12050658A patent/CO6531419A2/es unknown
- 2012-04-16 ZA ZA2012/02761A patent/ZA201202761B/en unknown
-
2014
- 2014-06-05 US US14/296,832 patent/US20160051472A9/en not_active Abandoned
-
2016
- 2016-05-26 IL IL245875A patent/IL245875A0/en unknown
- 2016-06-17 HK HK16107000.5A patent/HK1218886A1/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013505255A5 (enExample) | ||
| MX2013003627A (es) | Formulaciones de pancrelipasa con recubrimiento enterico de baja potencia. | |
| RU2012113253A (ru) | Композиции панкреатических ферментов и способы лечения панкреатита и недостаточности поджелудочной железы | |
| JP2014512390A5 (enExample) | ||
| NZ590291A (en) | Pharmaceutical compositions for treatment of parkinson's disease | |
| ZA200807778B (en) | Reverse-Phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations WDG-CS, ZC, EC-SC and CX | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| IN2014MN00139A (enExample) | ||
| WO2006035434A3 (en) | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases | |
| WO2007029249A3 (en) | Oligoribonucleotides and methods of use thereof for treatment of cardiovascular diseases | |
| WO2012013331A3 (en) | Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases | |
| JP2015523321A5 (enExample) | ||
| WO2011139044A3 (ko) | 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제 | |
| NZ700824A (en) | Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients | |
| JP2016530279A5 (enExample) | ||
| WO2016073179A2 (en) | Novel chronotherapy based on circadian rhythms | |
| WO2012067481A3 (es) | Composición farmacéutica de administración oral para el tratamiento del síndrome de intestino irritable, a base de un modificador de la motilidad intestinal, un agente que previene la retención de gases y enzimas digestivas y proceso para su preparación | |
| WO2008031835A3 (en) | Method of treating autoimmune diseases using vegf-pathway inhibitors | |
| BRPI0513598A (pt) | formas de dosagem em comprimidos revestidos de liberação entérica | |
| WO2011093818A3 (en) | Pharmaceutical compositions comprising salmeterol and fluticasone | |
| GEP20156386B (en) | New crystal form vii of agomelatine, preparation method and usage thereof, and pharmaceutical compositions containing thereof | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
| JP2009505991A5 (enExample) | ||
| WO2013098268A3 (en) | Tablets and dry-coated agents | |
| WO2012067482A3 (es) | COMPOSICIÓN FARMACÉUTICA ADAPTADA PARA ADMINISTRARSE ORALMENTE Y PROCESO PARA SU PREPARACIÓN, PARA PREVENCIÓN Y TRATAMIENTO DEL SÍNDROME DE INTESTINO IRRITABLE, A BASE DE UN MODIFICADOR DE LA MOTILIDAD INTESTINAL Y α-D-GALAGTOSIDASA |